StockData
Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$2.04−1.16 (-36.25%)

Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –

Kyntra Bio cash

Cash and short-term investments held at the end of each period.

Kyntra Bio's cash was $91.32M at Jun 30, 2026. For fiscal 2025 it was $88.98M, up 76.3% from the year before. Over ten years it grew -6.9% a year on average. The highest annual figure on record is $735.72M in fiscal 2017.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.98M+76.3%
FY2024Dec 31, 2024$50.48M-75.2%
FY2023Dec 31, 2023$203.45M-51.8%
FY2022Dec 31, 2022$422.01M+4.2%
FY2021Dec 31, 2021$405.19M-41.0%
FY2020Dec 31, 2020$686.54M+28.6%
FY2019Dec 31, 2019$533.76M-14.1%
FY2018Dec 31, 2018$621.40M-15.5%
FY2017Dec 31, 2017$735.72M+190.6%
FY2016Dec 31, 2016$253.18M+39.7%
FY2015Dec 31, 2015$181.17M+0.8%
FY2014Dec 31, 2014$179.82M+135.6%
FY2013Dec 31, 2013$76.33M+96.4%
FY2012Dec 31, 2012$38.87M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$91.32M+290.8%
Q1 FY2026Mar 31, 2026$87.24M+159.6%
Q4 FY2025Dec 31, 2025$88.98M+76.3%
Q3 FY2025Sep 30, 2025$117.98M-9.9%
Q2 FY2025Jun 30, 2025$23.37M-83.4%
Q1 FY2025Mar 31, 2025$33.61M-81.1%
Q4 FY2024Dec 31, 2024$50.48M-75.2%
Q3 FY2024Sep 30, 2024$131.00M-47.9%
Q2 FY2024Jun 30, 2024$140.71M-58.1%
Q1 FY2024Mar 31, 2024$177.60M-50.1%
Q4 FY2023Dec 31, 2023$203.45M-51.8%
Q3 FY2023Sep 30, 2023$251.34M-38.5%
Q2 FY2023Jun 30, 2023$335.72M-23.4%
Q1 FY2023Mar 31, 2023$355.95M-16.8%
Q4 FY2022Dec 31, 2022$422.01M+4.2%
Q3 FY2022Sep 30, 2022$408.52M-16.0%
Q2 FY2022Jun 30, 2022$438.13M-13.6%
Q1 FY2022Mar 31, 2022$428.08M-21.3%
Q4 FY2021Dec 31, 2021$405.19M-41.0%
Q3 FY2021Sep 30, 2021$486.40M-29.3%
Q2 FY2021Jun 30, 2021$507.21M-26.0%
Q1 FY2021Mar 31, 2021$544.23M+1.6%
Q4 FY2020Dec 31, 2020$686.54M+28.6%
Q3 FY2020Sep 30, 2020$687.87M+9.4%
Q2 FY2020Jun 30, 2020$685.59M+3.8%
Q1 FY2020Mar 31, 2020$535.43M-5.3%
Q4 FY2019Dec 31, 2019$533.76M-14.1%
Q3 FY2019Sep 30, 2019$628.63M-3.7%
Q2 FY2019Jun 30, 2019$660.76M-1.7%
Q1 FY2019Mar 31, 2019$565.40M-19.7%
Q4 FY2018Dec 31, 2018$621.40M-15.5%
Q3 FY2018Sep 30, 2018$652.73M-10.6%
Q2 FY2018Jun 30, 2018$671.90M+87.0%
Q1 FY2018Mar 31, 2018$703.77M+189.1%
Q4 FY2017Dec 31, 2017$735.72M+190.6%
Q3 FY2017Sep 30, 2017$729.97M+201.9%
Q2 FY2017Jun 30, 2017$359.40M–
Q1 FY2017Mar 31, 2017$243.42M–
Q4 FY2016Dec 31, 2016$253.18M–
Q3 FY2016Sep 30, 2016$241.81M–

More Kyntra Bio figures

See a number that looks wrong?